Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical ...

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.

According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.

It happened again on Thursday morning, when Cigna Group reported quarterly earnings. The results missed estimates and management’s financial guidance for next year was lower than Wall Street expected.

Shares of The Cigna Group fell more than 10% on Thursday morning, hitting intraday lows not seen since early January, following a quarterly profit miss. Fourth-quarter (Q4) adjusted earnings per share ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

An analysis from health policy charity Kaiser Family Foundation (KFF) evaluated nearly 400million claims made to insurance ...

Fresh off underperforming Wall Street’s expectations in the fourth quarter, Cigna said it would work to lower costs for its ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

Sees FY25 adjusted revenue at least $252,000. Sees FY25 capital expenditures $1.4B. Sees FY25 effective tax rate 19%. The company said, “The ...

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...